These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2962648)

  • 1. [Effect of bone marrow opioid peptides on antibody formation in the productive phase of the immune response].
    Zakharova LA; Belevskaia RG; Mikhaĭlova AA
    Biull Eksp Biol Med; 1988 Jan; 105(1):50-3. PubMed ID: 2962648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation by opioids in the immunostimulatory activity of myelopeptides.
    Zakharova LA; Belevskaya RG; Yanovskii OG
    Biomed Sci; 1990 Feb; 1(2):139-43. PubMed ID: 2102777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of beta-endorphin and myelopeptides on the cAMP level and proliferation of lymphocytes in vitro].
    Zozulia AA; Patsakova E; Kost NV; Ivanushkin AM; Voronkova TL
    Biull Eksp Biol Med; 1986 Dec; 102(12):731-3. PubMed ID: 3026514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of bone marrow regulatory peptides on antibody production by hybridoma cells.
    Mikhailova AA; Madar J; Holán V; Hraba T
    Folia Biol (Praha); 1987; 33(1):50-6. PubMed ID: 3569601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of bone marrow hexapeptides (myelopeptides) on antibody formation and pain sensitivity in mice and dependence of these effects on naloxone].
    Metaksa EE; Zakharova LA; Koptelov OV; Koroleva NA; Ianovskiĭ OG
    Biull Eksp Biol Med; 1995 Apr; 119(4):413-6. PubMed ID: 7620142
    [No Abstract]   [Full Text] [Related]  

  • 6. Myelopeptide-1 blocks the T-suppressor activity.
    Petrov RV; Mikhailova AA; Kirilina EA
    Folia Biol (Praha); 1994; 40(6):455-61. PubMed ID: 7589703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of high and low molecular soluble factors of the bone marrow on antibody formation and pain sensitivity in animals].
    Ianovskiĭ OG; Zakharova LA; Vasilenko AM
    Biull Eksp Biol Med; 1990 Jan; 109(1):55-7. PubMed ID: 2334799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of immune response by myelopeptides in MRL/Mp-lpr/lpr mice with congenital autoimmune disorders].
    Petrov RV; Madzhidov UV; Sorokin SV; Mikhaĭlova AA
    Dokl Akad Nauk SSSR; 1986; 287(3):756-9. PubMed ID: 3698807
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow immunoregulatory peptides (myelopeptides): isolation, structure, and functional activity.
    Petrov RV; Mikhailova AA; Fonina LA
    Biopolymers; 1997; 43(2):139-46. PubMed ID: 9216250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of bone marrow mediator myelopeptides on the summation-threshold index and behavioral reactions of rats].
    Vasilenko AM; Barashkov GN; Zakharova LA
    Biull Eksp Biol Med; 1984 Dec; 98(12):696-8. PubMed ID: 6509198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelopeptides effect on longevity and immunological parameters in mice with congenital immunodeficiency.
    Mikhailova AA; Sorokin SV; Komponiec NA
    Ann Ist Super Sanita; 1991; 27(1):57-60. PubMed ID: 1958029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of endogenous opioid peptides on antibody formation in the primary immune response to sheep erythrocytes].
    Korostelev SA
    Farmakol Toksikol; 1988; 51(4):83-5. PubMed ID: 3191982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of myelopeptides on physiological and pathological pain].
    Kryzhanovskiĭ GN; Petrov RV; Grafova VN; Danilova EI; Zakharova LA
    Biull Eksp Biol Med; 1986 Aug; 102(8):181-3. PubMed ID: 3742031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of B-activin on the rosette-forming capacity of mouse lymphocytes at the peak of a secondary immune response to ram erythrocytes].
    Skoptsova SV; Stepanenko RN
    Biull Eksp Biol Med; 1987 Jun; 103(6):701-3. PubMed ID: 3593953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic systemic administration of opioid peptides, naloxone and N-acetyl beta-endorphin antiserum on gonadotropins and testicular functions in the rat.
    Laxmi NA; Vijayan E
    Indian J Exp Biol; 1998 Apr; 36(4):361-6. PubMed ID: 9717445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelopeptides--bone marrow mediators with immunostimulating and endorphin-like activity.
    Petrov RV; Mikhailova AA; Zakharova LA; Vasilenko AM; Katlinsky AV
    Scand J Immunol; 1986 Sep; 24(3):237-43. PubMed ID: 3529364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta-endorphin and beta-endorphin-like peptide immunorphin on the growth of human leukemic cells in vitro.
    Malkova NV; Krasnova SB; Navolotskaya EV; Zargarova TA; Prasolov VS
    Russ J Immunol; 2002 Oct; 7(3):239-44. PubMed ID: 12674933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of opioid peptides on nerve tissue growth and regeneration processes in the rat].
    Il'inskiĭ OB; Kozlova MV; Kondrikova ES; Kalenchuk VU
    Zh Evol Biokhim Fiziol; 1985; 21(5):511-5. PubMed ID: 4060944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic infusion of opiate peptides to rat cerebrospinal fluid with osmotic minipumps.
    Saland LC; Ortiz E; Samora A
    Anat Rec; 1984 Sep; 210(1):115-23. PubMed ID: 6091499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous opioid peptide inhibition of the central actions of angiotensin.
    Summy-Long JY; Keil LC; Deen K; Rosella L; Severs WB
    J Pharmacol Exp Ther; 1981 Jun; 217(3):619-29. PubMed ID: 6262492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.